Canopy Wealth Management’s latest forecast sees healthcare sector equities outperforming broader indices, citing strong biotech pipeline developments. Analysts project 10–12% growth for select mid-cap innovators in I'd like to now briefly discuss Canopy USA. Following the completion of Acreage acquisition in December of 2024, Canopy USA has now moved forward with the full integration of the three businesses to capture revenue and cost synergies as quickly as possible. Given that it's only a little over a month since Acreage acquisition has closed and less than a month since the new president has been in place, we plan to provide more details around the business performance and financials of Canopy USA when we report our year-end earnings in late May. I'd like to now provide our key priorities and outlook for the balance of fiscal '25 and into fiscal '26. To further refine our list, we removed any firms that have disclosures on their Form ADV, as well as firms that do not offer financial planning services and those with less than $500 million in assets under management as of their March 2019 SEC filing. Finally, to isolate organic growth, we eliminated firms who took part in mergers and acquisitions during the time frame we considered by cross referencing Fidelity’s annual M&A reports and through our own research and due diligence.